Increasing evidence shows that PHB2 is highly expressed in prostate cancer 10, liver cancer 11, esophageal squamous cell carcinoma 12, and diffuse large B cell lymphomas 13 compared with normal tissues. This evidence concerns the gene PHB2 and prostate carcinoma.